Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$7.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 9 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 11 business days late.
The 28 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| May 20 | BTAI | BioXcel Therapeutics, Inc. | SSELL◷ | 6,560 | $1.08 | $7.1K | -19.7% | Open the original filing on SEC.gov |
| May 4 | BTAI | BioXcel Therapeutics, Inc. | MEXER◷◆ | 17,500 | — | — | — | Open the original filing on SEC.gov |
| May 4 | BTAI | BioXcel Therapeutics, Inc. | MEXER◷ | 17,500 | — | — | +110.3% | Open the original filing on SEC.gov |
| May 1 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 9,000 | — | — | — | Open the original filing on SEC.gov |
| May 1 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 9,000 | — | — | +131.1% | Open the original filing on SEC.gov |
| Mar 15 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 35 | — | — | — | Open the original filing on SEC.gov |
| Mar 15 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 35 | — | — | +0.5% | Open the original filing on SEC.gov |
| Mar 14 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 33 | — | — | — | Open the original filing on SEC.gov |
| Mar 14 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 33 | — | — | +0.5% | Open the original filing on SEC.gov |
| Jan 1 | BTAI | BioXcel Therapeutics, Inc. | AGRANT◆ | 70,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 15, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 35 | — | — | — | Open the original filing on SEC.gov |
| Dec 15, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 35 | — | — | +0.5% | Open the original filing on SEC.gov |
| Dec 14, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 33 | — | — | — | Open the original filing on SEC.gov |
| Dec 14, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 33 | — | — | +0.5% | Open the original filing on SEC.gov |
| Sep 15, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 35 | — | — | — | Open the original filing on SEC.gov |
| Sep 15, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 35 | — | — | +0.5% | Open the original filing on SEC.gov |
| Sep 14, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 33 | — | — | — | Open the original filing on SEC.gov |
| Sep 14, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 33 | — | — | +0.5% | Open the original filing on SEC.gov |
| Aug 1, 2025 | BTAI | BioXcel Therapeutics, Inc. | AGRANT◆ | 9,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 22, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 625 | — | — | — | Open the original filing on SEC.gov |
| Jul 22, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 625 | — | — | +10.4% | Open the original filing on SEC.gov |
| Jul 22, 2025 | BTAI | BioXcel Therapeutics, Inc. | AGRANT | 4,375 | — | — | +263.7% | Open the original filing on SEC.gov |
| Jun 15, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 35 | — | — | — | Open the original filing on SEC.gov |
| Jun 15, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 35 | — | — | +2.2% | Open the original filing on SEC.gov |
| Jun 14, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 33 | — | — | — | Open the original filing on SEC.gov |
| Jun 14, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 33 | — | — | +2.1% | Open the original filing on SEC.gov |